Echocardiographic predictors of outcome in severe aortic stenosis patients with preserved or reduced ejection fraction.

ABSTRACT:

Aims

Transcatheter aortic valve implantation (TAVI) has emerged as the treatment of choice for many patients with severe symptomatic aortic stenosis. We sought to identify the echocardiographic predictors of 30-day and 1-year outcomes after TAVI in patients with preserved or reduced left ventricular ejection fraction (LVEF).

Methods

This single-centre study included 618 aortic stenosis patients (mean age 82 ± 6 years, 47.1% male; 74.8% LVEF > 50%) who underwent balloon-expandable TAVI between July 2009 and October 2018 in our hospital. All patients completed at least 6 months of follow-up by medical history review or telephone interview (median 24, quartiles 12-42 months). The primary endpoint was all-cause death.

Results

All-cause mortality rate was 5.2% (LVEF > 50%:

SUBMITTER: Sokalski V 

PROVIDER: S-EPMC10881626 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature